1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: JX594-CRC019, NCT01394939
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: JX594-HEP016, NCT01171651
|
|
3.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: JX594-HEP018, NCT01387555
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: JX594-IV-HEP021, NCT01636284
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 21 Sponsor: Pharmaceutical / Industry Protocol IDs: JX594-IT-P009, NCT01169584
|
|
6.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: JX594-IV-CRC014, NCT01380600
|